What is the Q/C Technologies, Inc. stock price forecast?

Q/C Technologies, Inc. is currently trading at $3.87. View real-time AI analysis on Alpha Lenz.

What is Q/C Technologies, Inc. insider trading activity?

View the latest insider trading data for Q/C Technologies, Inc. on Alpha Lenz.

What is Q/C Technologies, Inc.'s P/E ratio?

View Q/C Technologies, Inc.'s valuation metrics on Alpha Lenz.

Q/C Technologies, Inc.

NASDAQ · QCLS

$3.87+0.05(+1.31%)Pre-market

Ask about Q/C Technologies, Inc.'s future dividend policy...

Alpha Chat Insight

“Q/C Technologies, Inc.'s ROE is -63.8%. Explore profitability and growth together.”

Ask for details →

Company Overview

Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.

Websitehttps://tnfpharma.com

SectorTechnology

IndustryComputer Hardware

Employees6

Company Statistics

FY 2025

Profile

N/AMarket Cap

$0.00Revenue

0.00Shares Out

6Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-37.16%ROA

-63.76%ROE

-30.62%ROIC

Financial Health

$987.00KCash & Cash Equivalents

$18.43MNet Debt

89.25%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Q/C Technologies, Inc.'s ROE is -63.8%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Q/C Technologies, Inc. (ticker: QCLS) is a company listed on NASDAQ in the Technology sector (Computer Hardware). It has approximately 6 employees.

The current price is $3.87 with a P/E ratio of -x and P/B of -x.

ROE is -63.76%.